Charles Moore
Stock Analyst at Robert W. Baird
(2.96)
# 2,719
Out of 4,609 analysts
7
Total ratings
71.4%
Success rate
19.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Moore
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics | Maintained: Buy | $32 → $34 | $24.73 | +37.48% | 2 | Apr 7, 2026 | |
| CTNM Contineum Therapeutics | Maintained: Buy | $14 → $20 | $15.35 | +30.29% | 2 | Mar 6, 2026 | |
| DRUG Bright Minds Biosciences | Maintained: Buy | $142 → $126 | $80.80 | +55.94% | 3 | Feb 13, 2026 |
Denali Therapeutics
Apr 7, 2026
Maintained: Buy
Price Target: $32 → $34
Current: $24.73
Upside: +37.48%
Contineum Therapeutics
Mar 6, 2026
Maintained: Buy
Price Target: $14 → $20
Current: $15.35
Upside: +30.29%
Bright Minds Biosciences
Feb 13, 2026
Maintained: Buy
Price Target: $142 → $126
Current: $80.80
Upside: +55.94%